A Bacterial Reporter System for the Evaluation of Antisense Oligodeoxynucleotides Directed against Human Papillomavirus Type 16 (HPV-16)

Archives of Medical Research

Volumn 37, Issue 5, 2006, Pages 584-592

  Guapillo, Mario R ^a   Márquez, Miguel A ^a   Benítez Hess, María L ^a   Alvarez Salas, Luis M ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Antisense; Green fluorescent protein; Oligodeoxynucleotides; Papillomavirus; Therapeutic oligonucleotides

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYAN FLUORESCENT PROTEIN; MESSENGER RNA; PLASMID VECTOR; RIBONUCLEASE H;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BACTERIAL STRAIN; BACTERIUM; CHIMERA; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG TARGETING; ENZYME ASSAY; ESCHERICHIA COLI; EVALUATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MOLECULAR MODEL; NONHUMAN; PROTEIN EXPRESSION; REPORTER GENE; UTERINE CERVIX TUMOR;

CELL LINE, TUMOR; DRUG EVALUATION, PRECLINICAL; ESCHERICHIA COLI; GENES, REPORTER; HUMAN PAPILLOMAVIRUS 16; HUMANS; OLIGODEOXYRIBONUCLEOTIDES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS;

EID: 33646857275     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2005.11.006     Document Type: Article

References (40)

1. Zamecnik P.C., and Stephenson M.L. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci USA 75 (1978) 280-284
2. Calabretta B. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications. Cancer Res 51 (1991) 4505-4510
3. Persaud S.J., and Jones P.M. Antisense oligonucleotide inhibition of gene expression: application to endocrine systems. J Mol Endocrinol 12 (1994) 127-130
4. Anazodo M.I., Wainberg M.A., Friesen A.D., and Wright J.A. Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome. J Virol 69 (1995) 1794-1801
5. Nichols G.L. Antisense oligodeoxynucleotides as therapeutic agents for chronic myelogenous leukemia. Antisense Res Dev 5 (1995) 67-69
6. Reed J.C., Stein C., Subasinghe C., Haldar S., Croce C.M., Yum S., et al. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res 50 (1990) 6565-6570
7. Morrison R.S. Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J Biol Chem 266 (1991) 728-734
8. Skorski T., Szczylik C., Malaguarnera L., and Calabretta B. Gene-targeted specific inhibition of chronic myeloid leukemia cell growth by BCR-ABL antisense oligodeoxynucleotides. Folia Histochem Cytobiol 29 (1991) 85-89
9. Vickers T.A., Wyatt J.R., and Freier S.M. Effects of RNA secondary structure on cellular antisense activity. Nucleic Acids Res 28 (2000) 1340-1347
10. Holen T., Amarzguioui M., Wiiger M.T., Babaie E., and Prydz H. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res 30 (2002) 1757-1766
11. Miyagishi M., Hayashi M., and Taira K. Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells. Antisense Nucleic Acid Drug Dev 13 (2003) 1-7
12. Scherr M., Reed M., Huang C.F., Riggs A.D., and Rossi J.J. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase. Mol Ther 2 (2000) 26-38
13. Agrawal S., Jiang Z., Zhao Q., Shaw D., Cai Q., Roskey A., et al. Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies. Proc Natl Acad Sci USA 94 (1997) 2620-2625
14. Agrawal S., and Zhao Q. Mixed backbone oligonucleotides: improvement in oligonucleotide-induced toxicity in vivo. Antisense Nucleic Acid Drug Dev 8 (1998) 135-139
15. Wang Z., Inokuchi T., Nemoto T.K., Uehara M., and Baba T.T. Antisense oligonucleotide against collagen-specific molecular chaperone 47-kDa heat shock protein suppresses scar formation in rat wounds. Plast Reconstr Surg 111 (2003) 1980-1987
16. Bertrand J.R., Pottier M., Vekris A., Opolon P., Maksimenko A., and Malvy C. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun 296 (2002) 1000-1004
17. 't Hoen P.A., Rosema B.S., Commandeur J.N., Vermeulen N.P., Manoharan M., van Berkel T.J., et al. Selection of effective antisense oligodeoxynucleotides with a green fluorescent protein-based assay. Discovery of selective and potent inhibitors of glutathione S-transferase Mu expression. Eur J Biochem 269 (2002) 2574-2583
18. Tsien R.Y. The green fluorescent protein. Annu Rev Biochem 67 (1998) 509-544
19. Chalfie M., Tu Y., Euskirchen G., Ward W.W., and Prasher D.C. Green fluorescent protein as a marker for gene expression. Science 263 (1994) 802-805
20. Albano C.R., Randers-Eichhorn L., Bentley W.E., and Rao G. Green fluorescent protein as a real time quantitative reporter of heterologous protein production. Biotechnol Prog 14 (1998) 351-354
21. Cha H.J., Wu C.F., Valdes J.J., Rao G., and Bentley W.E. Observations of green fluorescent protein as a fusion partner in genetically engineered Escherichia coli: monitoring protein expression and solubility. Biotechnol Bioeng 67 (2000) 565-574
22. Chung C.T., Niemela S.L., and Miller R.H. One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc Natl Acad Sci USA 86 (1989) 2172-2175
23. Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol 166 (1983) 557-580
24. Alvarez-Salas L.M., Cullinan A.E., Siwkowski A., Hampel A., and DiPaolo J.A. Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes. Proc Natl Acad Sci USA 95 (1998) 1189-1194
25. Alvarez-Salas L.M., Arpawong T.E., and DiPaolo J.A. Growth inhibition of cervical tumor cells by antisense oligodeoxynucleotides directed to the human papillomavirus type 16 E6 gene. Antisense Nucleic Acid Drug Dev 9 (1999) 441-450
26. Benitez-Hess M.L., DiPaolo J.A., and Alvarez-Salas L.M. Antisense activity detection by inhibition of fluorescence resonance energy transfer. Luminescence 19 (2004) 85-93
27. Su P.F., and Wu F.Y. Differential suppression of the tumorigenicity of HeLa and SiHa cells by adeno-associated virus. Br J Cancer 73 (1996) 1533-1537
28. Yoshinouchi M., Yamada T., Kizaki M., Fen J., Koseki T., Ikeda Y., et al. In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. Mol Ther 8 (2003) 762-768
29. Crook T., Wrede D., Tidy J., Scholefield J., Crawford L., and Vousden K.H. Status of c-myc, p53 and retinoblastoma genes in human papillomavirus positive and negative squamous cell carcinomas of the anus. Oncogene 6 (1991) 1251-1257
30. Galderisi U., Cascino A., and Giordano A. Antisense oligonucleotides as therapeutic agents. J Cell Physiol 181 (1999) 251-257
31. Sohail M., and Southern E.M. Using oligonucleotide scanning arrays to find effective antisense reagents. Methods Mol Biol 170 (2003) 181-199
32. Stein C.A., and Cheng Y.C. Antisense oligonucleotides as therapeutic agents-is the bullet really magical?. Science 261 (1993) 1004-1012
33. Stein C.A., and Krieg A.M. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res Dev 4 (1994) 67-69
34. Muller M., Dietel M., Turzynski A., and Wiechen K. Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells. Int J Cancer 77 (1998) 567-571
35. Kim J.Y., and Cha H.J. Down-regulation of acetate pathway through antisense strategy in Escherichia coli: improved foreign protein production. Biotechnol Bioeng 83 (2003) 841-853
36. Ferre-D'Amare A.R., and Rupert P.B. The hairpin ribozyme: from crystal structure to function. Biochem Soc Trans 30 (2001) 1105-1109
37. Alvarez-Salas L.M., Benitez-Hess M.L., and DiPaolo J.A. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses. Antivir Ther 8 (2003) 265-278
38. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
39. Hutvagner G., McLachlan J., Pasquinelli A.E., Balint E., Tuschl T., and Zamore P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293 (2001) 834-838
40. Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G., and Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 15 (2004) 185-197